U.S., June 5 -- ClinicalTrials.gov registry received information related to the study (NCT07626567) titled 'Prospective Neuropsychological Evaluation of the Implementation of a Heart Valve Unit (HVU-NEURO)' on May 21.
Brief Summary: Transcatheter aortic valve implantation (TAVI) is an established treatment for severe aortic stenosis. Despite improved procedural outcomes, neurocognitive complications such as postoperative delirium (POD) and postoperative cognitive decline (POCD) remain clinically relevant.
Heart Valve Units (HVU) are specialized interdisciplinary care structures designed to improve treatment pathways and healthcare quality. However, their impact on neuropsychological outcomes has not been sufficiently investigated.
HVU-NE...